Skip to main content
. 2016 Aug 2;36(7):656–666. doi: 10.1007/s10875-016-0321-2

Table 2.

Clinical characteristics for known CSR patients at presentation

Patient CD40L #1 CD40L #2 AID #1 AID #2 UNG
Year of birth 1985 1980 1975 1972 1994
Gender Male Male Female Male Male
Age at diagnosis 3 2 20 6 3
Clinical presentation
Bronchiectasis Rec. neutropenia Vasculitis Rec. lung infections Rec. lung infections
Sinusitis HUS Rec. breast abces Bronchiectasis Rec. Otitis
Cold sores Meningococcal meningitis Failure to thrive
Urticaria Cutaneous lupus
Gene analysis
CD40L c.464T>C, (p. Leu155Pro) c.435delC
UNG c.630_632delCCT
AICDA c.156+1T>G c.317T>C (p. L106P)
Immunoglobulins at presentation (g/L)
IgG 1.5 <0.1 <0.1 <0.1 <0.1
IgM 7.5 3.5 9.0 ND 0.5
IgA <0.22 <0.1 <0.1 ND <0.1
IgE <2 ND ND ND ND
B cell subsets at presentation
IgD+CD27− (naive) 92 ND ND ND 68.6
IgD+CD27+ (non-switched memory) 7 ND ND ND 27.4
IgD−CD27+ (switched-memory) 0 ND ND ND 2.4
IgD−CD27− (double negative) 1 ND ND ND 1.6